• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于肠道的策略来降低 2 型糖尿病的餐后血糖

Gut-Based Strategies to Reduce Postprandial Glycaemia in Type 2 Diabetes.

机构信息

Department of Applied Nutrition and Food Technology, Islamic University, Kushtia, Bangladesh.

Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.

出版信息

Front Endocrinol (Lausanne). 2021 Apr 9;12:661877. doi: 10.3389/fendo.2021.661877. eCollection 2021.

DOI:10.3389/fendo.2021.661877
PMID:33897622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8062751/
Abstract

Postprandial glycemic control is an important target for optimal type 2 diabetes management, but is often difficult to achieve. The gastrointestinal tract plays a major role in modulating postprandial glycaemia in both health and diabetes. The various strategies that have been proposed to modulate gastrointestinal function, particularly by slowing gastric emptying and/or stimulating incretin hormone GLP-1, are summarized in this review.

摘要

餐后血糖控制是优化 2 型糖尿病管理的重要目标,但往往难以实现。胃肠道在调节健康和糖尿病患者的餐后血糖方面发挥着重要作用。本综述总结了各种旨在调节胃肠道功能的策略,特别是通过减缓胃排空和/或刺激肠促胰岛素 GLP-1。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/216b/8062751/fafb28b51400/fendo-12-661877-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/216b/8062751/3d94e93b3cc0/fendo-12-661877-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/216b/8062751/fafb28b51400/fendo-12-661877-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/216b/8062751/3d94e93b3cc0/fendo-12-661877-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/216b/8062751/fafb28b51400/fendo-12-661877-g002.jpg

相似文献

1
Gut-Based Strategies to Reduce Postprandial Glycaemia in Type 2 Diabetes.基于肠道的策略来降低 2 型糖尿病的餐后血糖
Front Endocrinol (Lausanne). 2021 Apr 9;12:661877. doi: 10.3389/fendo.2021.661877. eCollection 2021.
2
Cystic fibrosis related diabetes--a new perspective on the optimal management of postprandial glycemia.囊性纤维化相关性糖尿病——餐后血糖最佳管理的新视角
J Diabetes Complications. 2014 Nov-Dec;28(6):904-11. doi: 10.1016/j.jdiacomp.2014.06.012. Epub 2014 Jun 21.
3
A Protein Preload Enhances the Glucose-Lowering Efficacy of Vildagliptin in Type 2 Diabetes.蛋白负荷可增强维格列汀在 2 型糖尿病患者中的降糖疗效。
Diabetes Care. 2016 Apr;39(4):511-7. doi: 10.2337/dc15-2298. Epub 2016 Jan 19.
4
Pancreatic enzyme supplementation improves the incretin hormone response and attenuates postprandial glycemia in adolescents with cystic fibrosis: a randomized crossover trial.补充胰酶可改善囊性纤维化青少年的肠促胰岛素激素反应并减轻餐后血糖:一项随机交叉试验。
J Clin Endocrinol Metab. 2014 Jul;99(7):2486-93. doi: 10.1210/jc.2013-4417. Epub 2014 Mar 26.
5
Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes.十二指肠葡萄糖负荷变化对 2 型糖尿病患者血糖、胰岛素和肠降血糖素反应的影响。
Diabet Med. 2012 May;29(5):604-8. doi: 10.1111/j.1464-5491.2011.03496.x.
6
The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients.每日一次给予的人胰高血糖素样肽-1(GLP-1)类似物利拉鲁肽可改善 2 型糖尿病患者的餐后血糖水平。
Adv Ther. 2011 Mar;28(3):213-26. doi: 10.1007/s12325-010-0110-x. Epub 2011 Feb 17.
7
The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications.胰高血糖素样肽-1功能障碍在肥胖中的作用及潜在治疗意义。
Diabetes Obes Metab. 2014 Jan;16(1):9-21. doi: 10.1111/dom.12119. Epub 2013 May 26.
8
Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients.胆囊切除术后患者的餐后肠道激素反应和葡萄糖代谢。
Am J Physiol Gastrointest Liver Physiol. 2013 Feb 15;304(4):G413-9. doi: 10.1152/ajpgi.00435.2012. Epub 2012 Dec 28.
9
The incretin system ABCs in obesity and diabetes - novel therapeutic strategies for weight loss and beyond.肥胖与糖尿病中的肠促胰岛素系统基础知识——减肥及其他方面的新型治疗策略
Obes Rev. 2016 Jul;17(7):553-72. doi: 10.1111/obr.12421. Epub 2016 Apr 29.
10
Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation.囊性纤维化患者的胃排空、肠促胰岛素激素分泌和餐后血糖——胰酶补充的影响。
J Clin Endocrinol Metab. 2011 May;96(5):E851-5. doi: 10.1210/jc.2010-2460. Epub 2011 Mar 9.

引用本文的文献

1
Phytochemical Screening and Antidiabetic Potential of in Alloxan-Induced Diabetic Rats: Investigative Study Toward Possible Mechanism.四氧嘧啶诱导的糖尿病大鼠中[具体植物名称未给出]的植物化学筛选及抗糖尿病潜力:对可能机制的研究
Food Sci Nutr. 2025 Sep 1;13(9):e70870. doi: 10.1002/fsn3.70870. eCollection 2025 Sep.
2
Pectin and Its Beneficial Effect on Health: New Contributions in Research and the Need to Increase Fruits and Vegetables Consumption-A Review.果胶及其对健康的有益影响:研究的新进展以及增加水果和蔬菜摄入量的必要性——综述
Int J Mol Sci. 2025 Jul 17;26(14):6852. doi: 10.3390/ijms26146852.
3
A Specific Collagen Hydrolysate Improves Postprandial Glucose Tolerance in Normoglycemic and Prediabetic Mice and in a First Proof of Concept Study in Healthy, Normoglycemic and Prediabetic Humans.

本文引用的文献

1
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials.替尔泊肽(双重GIP和GLP-1受体激动剂)在2型糖尿病管理中的作用:SURPASS临床试验
Diabetes Ther. 2021 Jan;12(1):143-157. doi: 10.1007/s13300-020-00981-0. Epub 2020 Dec 15.
2
Effects of Artificial Sweetener Consumption on Glucose Homeostasis and Its Association with Type 2 Diabetes and Obesity.人工甜味剂消费对葡萄糖稳态的影响及其与2型糖尿病和肥胖症的关联。
Int J Gen Med. 2020 Oct 6;13:775-785. doi: 10.2147/IJGM.S274760. eCollection 2020.
3
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus.
一种特定的胶原蛋白水解物可改善血糖正常和糖尿病前期小鼠的餐后葡萄糖耐量,并在一项针对健康、血糖正常和糖尿病前期人群的首次概念验证研究中得到证实。
Food Sci Nutr. 2024 Oct 20;12(11):9607-9620. doi: 10.1002/fsn3.4538. eCollection 2024 Nov.
4
GC-MS analysis, molecular docking, and pharmacokinetic studies on Dalbergia sissoo barks extracts for compounds with anti-diabetic potential.GC-MS 分析、分子对接和药代动力学研究,以确定紫檀树皮提取物中具有抗糖尿病潜力的化合物。
Sci Rep. 2024 Oct 22;14(1):24936. doi: 10.1038/s41598-024-75570-3.
5
Suppression of the postprandial hyperglycemia in patients with type 2 diabetes by a raw medicinal herb powder is weakened when consumed in ordinary hard gelatin capsules: A randomized crossover clinical trial.中药生药粉末普通硬胶囊制剂对 2 型糖尿病患者餐后高血糖的抑制作用减弱:一项随机交叉临床试验。
PLoS One. 2024 Oct 9;19(10):e0311501. doi: 10.1371/journal.pone.0311501. eCollection 2024.
6
Twelve Weeks of Daily Lentil Consumption Improves Fasting Cholesterol and Postprandial Glucose and Inflammatory Responses-A Randomized Clinical Trial.连续十二周食用小扁豆可改善空腹胆固醇和餐后血糖及炎症反应:一项随机临床试验。
Nutrients. 2024 Jan 31;16(3):419. doi: 10.3390/nu16030419.
7
Basal insulin intensification with GLP-1RA and dual GIP and GLP-1RA in patients with uncontrolled type 2 diabetes mellitus: A rapid review of randomized controlled trials and meta-analysis.在未经控制的 2 型糖尿病患者中,用 GLP-1RA 和双重 GIP 和 GLP-1RA 进行基础胰岛素强化治疗:随机对照试验和荟萃分析的快速综述。
Front Endocrinol (Lausanne). 2022 Sep 8;13:920541. doi: 10.3389/fendo.2022.920541. eCollection 2022.
8
Inhibition of Dipeptidyl Peptidase-4 by Flavonoids: Structure-Activity Relationship, Kinetics and Interaction Mechanism.黄酮类化合物对二肽基肽酶-4的抑制作用:构效关系、动力学及相互作用机制
Front Nutr. 2022 May 12;9:892426. doi: 10.3389/fnut.2022.892426. eCollection 2022.
二肽基肽酶 4 抑制剂在 2 型糖尿病治疗中的应用。
Nat Rev Endocrinol. 2020 Nov;16(11):642-653. doi: 10.1038/s41574-020-0399-8. Epub 2020 Sep 14.
4
Glucagon-like peptide-1 receptor agonists and the appropriate measurement of gastric emptying.胰高血糖素样肽-1受体激动剂与胃排空的恰当测量
Diabetes Obes Metab. 2020 Dec;22(12):2504-2506. doi: 10.1111/dom.14166. Epub 2020 Sep 3.
5
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist.替尔泊肽是一种失衡和偏倚的双重 GIP 和 GLP-1 受体激动剂。
JCI Insight. 2020 Sep 3;5(17):140532. doi: 10.1172/jci.insight.140532.
6
The novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long-acting GLP-1 receptor agonists.新型双重葡萄糖依赖性胰岛素促分泌素和胰高血糖素样肽-1(GLP-1)受体激动剂替西帕肽可暂时延缓胃排空,类似于选择性长效 GLP-1 受体激动剂。
Diabetes Obes Metab. 2020 Oct;22(10):1886-1891. doi: 10.1111/dom.14110. Epub 2020 Jul 13.
7
Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady-state concentrations.艾塞那肽每周一次可减缓稳态浓度下健康超重者的固体和液体胃排空。
Diabetes Obes Metab. 2020 May;22(5):788-797. doi: 10.1111/dom.13956. Epub 2020 Jan 28.
8
Advances in oral peptide therapeutics.口服肽治疗学的进展。
Nat Rev Drug Discov. 2020 Apr;19(4):277-289. doi: 10.1038/s41573-019-0053-0. Epub 2019 Dec 17.
9
Recent advances of GIP and future horizons.GIP 的最新进展和未来展望。
Peptides. 2020 Mar;125:170230. doi: 10.1016/j.peptides.2019.170230. Epub 2019 Dec 12.
10
Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date.口服司美格鲁肽用于2型糖尿病的管理:迄今证据报告
Diabetes Metab Syndr Obes. 2019 Dec 2;12:2515-2529. doi: 10.2147/DMSO.S229802. eCollection 2019.